tiprankstipranks
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Financial Statements

73 Followers

Revelation Biosciences Financial Overview

Revelation Biosciences's market cap is currently ―. The company's EPS TTM is $-30.784; its P/E ratio is -0.05; Revelation Biosciences is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-1.80. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.68M$ -2.63M$ -1.45M$ 6.16M$ -1.21M
EBITDA$ -2.68M$ -2.62M$ -1.44M$ 6.17M$ -1.20M
Net Income Common Stockholders$ -2.70M$ -2.63M$ -1.45M$ 6.16M$ -1.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 14.55M$ 13.99M$ 15.71M$ 17.70M$ 5.25M
Total Assets$ 14.70M$ 14.22M$ 16.04M$ 18.12M$ 5.50M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -14.55M$ -13.99M$ -15.71M$ -17.70M$ -5.25M
Total Liabilities$ 5.23M$ 5.40M$ 4.62M$ 8.10M$ 4.45M
Stockholders Equity$ 9.47M$ 8.82M$ 11.41M$ 10.02M$ 1.05M
Cash Flow-
Free Cash Flow$ -2.86M$ -1.72M$ -1.99M$ -1.58M$ -947.47K
Operating Cash Flow$ -2.84M$ -1.72M$ -1.99M$ -1.58M$ -947.47K
Investing Cash Flow$ -19.17K----
Financing Cash Flow$ 5.42M-$ 15.00$ 14.02M$ 5.00K
Currency in USD

Revelation Biosciences Earnings and Revenue History

Revelation Biosciences Debt to Assets

Revelation Biosciences Cash Flow

Revelation Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis